Learning and knowledge sharing are fundamental to the LHSS Project. We invite you to search LHSS knowledge products and resources for the latest approaches, insights, and learning in the field of integrated health systems strengthening.
LHSS conducted an assessment of the accuracy of drug scheduling tracking systems and developed recommendations to strengthen antiretroviral stockout and distribution monitoring.
This is the first study to assess, with validated methodology and questionnaires, the perception that patients and health professionals have about the ease of use, usefulness, and general satisfaction of an application for the registration of healthcare information created by MINSA.
LHSS tiene como objetivo fortalecer la capacidad del Ministerio de Salud para garantizar la disponibilidad de productos para el VIH (ARV y dispositivos médicos) para la población migrante venezolana en Perú. Como parte de este esfuerzo, LHSS estimó la demanda de productos relacionados con el VIH relacionados con esta población, incluidos detalles como el tipo, la cantidad y el momento.
This report provides a summary of the results of the quantification of demand for HIV commodities for the Venezuelan migrant population in Peru. It includes the capabilities and limitations of the quantification model, its approach to quantification, and the sources used.
This video captures a November 6, 2020 ceremony in Hanoi which marked the formal start of the LHSS Project’s four-year effort to help the Government of Vietnam implement its social health insurance program. The program covers treatment services for people with HIV, among other essential health services.
Working closely with the Vietnam Social Security (VSS) agency, LHSS will help improve the agency’s capacity to manage the insurance program funds effectively, efficiently, equitably, and with accountability. LHSS will also support Vietnam’s transition to full financial ownership of its HIV and TB responses.
HMED software will improve Vietnam’s capacity to effectively forecast ARV demand, and manage the drugs when they are in the country. Also, engaging drug manufacturers and distributors is crucial to overcoming supply side obstacles.